LAURA WARD: Open Payments
NPI 1225646870 · REISTERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,191 in 61 payments from 19 companies in 2025. Trend: 2023 $490 · 2024 $1,050 · 2025 $1,191
Food & beverage: $1,191
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $230 |
| ABBVIE INC. | 9 | $161 |
| AstraZeneca Pharmaceuticals LP | 7 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $93 |
| Novo Nordisk Inc | 4 | $88 |
| Exact Sciences Corporation | 3 | $78 |
| Astellas Pharma US Inc | 4 | $65 |
| Amgen Inc. | 3 | $55 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Lilly USA, LLC | 3 | $48 |
Products named: NURTEC ODT, Kerendia, BREZTRI, QULIPTA, Veozah, ELIQUIS, The Cologuard Plus Collection Kit, KRYSTEXXA.
Industry payments across MD — which companies pay providers there.
